PDA

View Full Version : PharmaMar's novel ADC demonstrates anticancer activity in HER2-expressing

News
11-09-2015, 04:31 AM
PharmaMar (MSE:PHM), a world-leading biopharmaceutical company in the discovery and development of innovative marine-derived anticancer drugs, has announced that its novel Antibody-Drug Conjugate...

More... (http://www.medicalnewstoday.com/releases/302258.php)